AKT1 and cancer: Similarly, Wu et al. (2017) utilized single-cell WES in colorectal adenoma and cancer samples, revealing their monoclonal origins, shared mutations in signaling pathways, and the emergence of intratumor heterogeneity, with nonrandom mutations accumulating in the GPCR, PI3K-Akt, and FGFR pathways [56].